Values First Advisors, Inc. Zoetis Inc. Transaction History

Values First Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$160.94 - $186.23 $9,978 - $11,546	-62 Reduced 3.26%	1,837 $316,000
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $13,966 - $16,801	96 Added 5.32%	1,899 $316,000
Q4 2022 Jan 20, 2023	BUY	$131.14 - $157.47 $13,638 - $16,376	104 Added 6.12%	1,803 $0
Q3 2022 Dec 02, 2022	SELL	$148.29 - $182.55 $6,673 - $8,214	-45 Reduced 2.58%	1,699 $252,000
Q2 2022 Jul 20, 2022	BUY	$155.97 - $200.09 $22,303 - $28,612	143 Added 8.93%	1,744 $300,000
Q1 2022 May 03, 2022	BUY	$181.39 - $234.03 $13,967 - $18,020	77 Added 5.05%	1,601 $302,000
Q4 2021 Mar 10, 2022	BUY	$193.69 - $247.03 $295,183 - $376,473	1,524 New	1,524 $372,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.